Thasneem, K.M. (2020) “SGLT2 Inhibitors: A Noval Therapuetic Agent in the Treatment of Diabetic Kidney Disease”, Journal of Drug Delivery and Therapeutics, 10(6), pp. 203–206. doi:10.22270/jddt.v10i6.4532.